3 ms·
Fair enough, for Moderna. Though my argument works better for J&J's numbers [1] with >$10B net income most years. [1] https://www.macrotrends.net/stocks/charts
by neolog 5y ago
Fair enough, for Moderna. Though my argument works better for J&J's numbers [1] with >$10B net income most years.
[1] https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/net-income https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnso...